Pfizer has been awarded a grant from the Bill & Melinda Gates Foundation to conduct a Phase I/II clinical trial of Pfizer’s vaccine candidate against group B Streptococcus (group B strep or GBS) infection. The investigational vaccine is designed to protect newborns via maternal immunization. Financial details of the grant were not disclosed.

Source: Pfizer